78 related articles for article (PubMed ID: 2416906)
1. Structure-activity relationship for substance P inhibition of carbamylcholine-stimulated 22Na+ flux in neuronal (PC12) and non-neuronal (BC3H1) cell lines.
Simasko SM; Soares JR; Weiland GA
J Pharmacol Exp Ther; 1985 Dec; 235(3):601-5. PubMed ID: 2416906
[TBL] [Abstract][Full Text] [Related]
2. Nicotinic receptor-elicited sodium flux in rat pheochromocytoma PC12 cells: effects of agonists, antagonists, and noncompetitive blockers.
Daly JW; Nishizawa Y; Edwards MW; Waters JA; Aronstam RS
Neurochem Res; 1991 Apr; 16(4):489-500. PubMed ID: 1922660
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the binding of [3H]substance P to the nicotinic acetylcholine receptor of Torpedo electroplaque.
Min CK; Owens J; Weiland GA
Mol Pharmacol; 1994 Feb; 45(2):221-7. PubMed ID: 7509439
[TBL] [Abstract][Full Text] [Related]
4. Two components of carbamylcholine-induced loss of nicotinic acetylcholine receptor function in the neuronal cell line PC12.
Simasko SM; Soares JR; Weiland GA
Mol Pharmacol; 1986 Jul; 30(1):6-12. PubMed ID: 3724745
[TBL] [Abstract][Full Text] [Related]
5. Effects of substance P on the binding of ligands to nicotinic acetylcholine receptors.
Weiland GA; Durkin JA; Henley JM; Simasko SM
Mol Pharmacol; 1987 Nov; 32(5):625-32. PubMed ID: 2446113
[TBL] [Abstract][Full Text] [Related]
6. Substance P inhibits carbamylcholine-stimulated 22Na+ efflux from acetylcholine receptor-enriched Torpedo electroplaque membrane vesicles.
Min CK; Weiland GA
Brain Res; 1992 Jul; 586(2):348-51. PubMed ID: 1381656
[TBL] [Abstract][Full Text] [Related]
7. Effects of forskolin and analogues on nicotinic receptor-mediated sodium flux, voltage-dependent calcium flux, and voltage-dependent rubidium efflux in pheochromocytoma PC12 cells.
Nishizawa Y; Seamon KB; Daly JW; Aronstam RS
Cell Mol Neurobiol; 1990 Sep; 10(3):351-68. PubMed ID: 1701359
[TBL] [Abstract][Full Text] [Related]
8. The beta subunit of neuronal nicotinic acetylcholine receptors is a determinant of the affinity for substance P inhibition.
Stafford GA; Oswald RE; Weiland GA
Mol Pharmacol; 1994 Apr; 45(4):758-62. PubMed ID: 7514262
[TBL] [Abstract][Full Text] [Related]
9. Anabaseine is a potent agonist on muscle and neuronal alpha-bungarotoxin-sensitive nicotinic receptors.
Kem WR; Mahnir VM; Papke RL; Lingle CJ
J Pharmacol Exp Ther; 1997 Dec; 283(3):979-92. PubMed ID: 9399967
[TBL] [Abstract][Full Text] [Related]
10. Conformationally constrained tachykinin analogs which are selective ligands for the eledoisin binding site.
Cascieri MA; Chicchi GG; Freidinger RM; Colton CD; Perlow DS; Williams B; Curtis NR; McKnight AT; Maguire JJ; Veber DF
Mol Pharmacol; 1986 Jan; 29(1):34-8. PubMed ID: 2418347
[TBL] [Abstract][Full Text] [Related]
11. Agonist-induced regulation of the neuronal nicotinic acetylcholine receptor of PC12 cells.
Robinson D; McGee R
Mol Pharmacol; 1985 Apr; 27(4):409-17. PubMed ID: 3982388
[TBL] [Abstract][Full Text] [Related]
12. Low affinity purinergic receptor modulates the response of rat submandibular glands to carbachol and substance P.
Métioui M; Amsallem H; Alzola E; Chaib N; Elyamani A; Moran A; Marino A; Dehaye JP
J Cell Physiol; 1996 Aug; 168(2):462-75. PubMed ID: 8707882
[TBL] [Abstract][Full Text] [Related]
13. Blockade of rat alpha3beta4 nicotinic receptor function by methadone, its metabolites, and structural analogs.
Xiao Y; Smith RD; Caruso FS; Kellar KJ
J Pharmacol Exp Ther; 2001 Oct; 299(1):366-71. PubMed ID: 11561100
[TBL] [Abstract][Full Text] [Related]
14. Effects of substance P on nicotinic acetylcholine receptor function in PC12 cells.
Simasko SM; Durkin JA; Weiland GA
J Neurochem; 1987 Jul; 49(1):253-60. PubMed ID: 2438382
[TBL] [Abstract][Full Text] [Related]
15. The muscarinic antagonists aprophen and benactyzine are noncompetitive inhibitors of the nicotinic acetylcholine receptor.
Amitai G; Herz JM; Bruckstein R; Luz-Chapman S
Mol Pharmacol; 1987 Nov; 32(5):678-85. PubMed ID: 3683366
[TBL] [Abstract][Full Text] [Related]
16. Binding of semirigid nicotinic agonists to nicotinic and muscarinic receptors.
Spivak CE; Waters JA; Aronstam RS
Mol Pharmacol; 1989 Jul; 36(1):177-84. PubMed ID: 2747625
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y (18-36) modulates chromaffin cell catecholamine secretion by blocking the nicotinic receptor ion channel.
Zheng J; Morrisett RA; Zhu J; Hexum TD
J Pharmacol Exp Ther; 1995 Aug; 274(2):891-7. PubMed ID: 7543575
[TBL] [Abstract][Full Text] [Related]
18. The "calcium antagonist" TMB-8 [3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester] is a potent, non-competitive, functional antagonist at diverse nicotinic acetylcholine receptor subtypes.
Bencherif M; Eisenhour CM; Prince RJ; Lippiello PM; Lukas RJ
J Pharmacol Exp Ther; 1995 Dec; 275(3):1418-26. PubMed ID: 8531111
[TBL] [Abstract][Full Text] [Related]
19. Effects of neuropeptide analogues on calcium flux and proliferation in lung cancer cell lines.
Bunn PA; Chan D; Stewart J; Gera L; Tolley R; Jewett P; Tagawa M; Alford C; Mochzuki T; Yanaihara N
Cancer Res; 1994 Jul; 54(13):3602-10. PubMed ID: 7516822
[TBL] [Abstract][Full Text] [Related]
20. Agonist-induced photoincorporation of a p-benzoylphenylalanine derivative of substance P into membrane-spanning region 2 of the Torpedo nicotinic acetylcholine receptor delta subunit.
Blanton MP; Li YM; Stimson ER; Maggio JE; Cohen JB
Mol Pharmacol; 1994 Dec; 46(6):1048-55. PubMed ID: 7528876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
